Showing 1 - 20 results of 262,912 for search '(((( 12 we decrease ) OR ( 10 ((_ decrease) OR (a decrease)) ))) OR ( 500 ms decrease ))*', query time: 1.65s Refine Results
  1. 1

    Increasing temperature decreases oxygen concentration and decreasing oxygen content decreases neuronal excitability. by Yuguo Yu (172221)

    Published 2012
    “…Increasing temperature can dramatically decrease oxygen levels. B. Response of layer 2/3 pyramidal cells (n = 5) to the intracellular injection of a depolarizing current pulse (200 pA, 500 ms) at different temperatures (same experiments as in A). …”
  2. 2
  3. 3
  4. 4
  5. 5

    Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia by Yiting Zhang (391974)

    Published 2016
    “…Thus our findings reveal a previously unrecognized decrease in brain vitamin B<sub>12</sub> status across the lifespan that may reflect an adaptation to increasing antioxidant demand, while accelerated deficits due to GSH deficiency may contribute to neurodevelopmental and neuropsychiatric disorders.…”
  6. 6

    Decreased Patrolling Efficiency and Decreased ConA Hepatitis Severity in CXCR6-Deficient Mice by Frederic Geissmann (75)

    Published 2013
    “…<div><p>(A) Serum transaminase levels in <i>cxcr6<sup>gfp/gfp</sup></i>, <i>cxcr6<sup>gfp/+</sup></i>, and <i>cxcr6<sup>+/+</sup></i> littermates 12 h after a challenge with 20 mg/kg ConA IP. …”
  7. 7

    Synaptic LTP decreases peak A-current density. by Sung-Cherl Jung (261358)

    Published 2009
    “…Dashed line indicates control amplitude. Scale bars 500 pA, 100 ms. B. Summarized changes of peak amplitude of transient (left panel) and sustained (right panel) currents. …”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial by Ma Somsouk (283498)

    Published 2014
    “…The effect of mesalamine in HIV-infected individuals, who exhibit abnormal mucosal immune activation and microbial translocation (MT), has not been established in a placebo-controlled trial. We randomized 33 HIV-infected subjects with CD4 counts <350 cells/mm<sup>3</sup> and plasma HIV RNA levels <40 copies/ml on antiretroviral therapy (ART) to add mesalamine vs. placebo to their existing regimen for 12 weeks followed by a 12 week crossover to the other arm. …”